Tebentafusp-tebn With LDT in Metastatic UM

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Uveal Melanoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Rino Seedor, MD) · ONCTrialNow@jefferson.edu · 215-600-9151
Contact: Principal Investigator (Rino Seedor, MD)
Marlana Orloff, MD (Sub-investigator)

Study leads

Rino Seedor, MD
Principal Investigator
Thomas Jefferson University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

Metastatic Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Tampa, United States

Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma

Uveal Melanoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma

Metastatic Uveal Melanoma · Metastatic Uveal Melanoma in the Liver

Abroad (travel likely)RecruitingPHASE2

Miami, United States

Adjuvant Tebentafusp in High Risk Ocular Melanoma

Uveal Melanoma

Abroad (travel likely)RecruitingPHASE3

Lake Success, United States · Brussels, Belgium